TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 46 filers reported holding TRICIDA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $779,000 | +3.2% | 167,863 | -3.9% | 0.04% | +6.1% |
| Q2 2021 | $755,000 | -18.3% | 174,763 | 0.0% | 0.03% | +3.1% |
| Q1 2021 | $924,000 | -25.0% | 174,763 | 0.0% | 0.03% | -41.8% |
| Q4 2020 | $1,232,000 | -22.2% | 174,763 | 0.0% | 0.06% | -39.6% |
| Q3 2020 | $1,583,000 | -67.0% | 174,763 | -0.0% | 0.09% | -73.5% |
| Q2 2020 | $4,803,000 | -58.4% | 174,764 | -66.7% | 0.34% | -67.1% |
| Q1 2020 | $11,534,000 | -79.5% | 524,290 | -63.2% | 1.04% | -80.2% |
| Q2 2019 | $56,212,000 | +90.4% | 1,424,525 | +82.4% | 5.27% | +78.9% |
| Q1 2019 | $29,529,000 | +60.4% | 781,185 | 0.0% | 2.94% | +25.2% |
| Q4 2018 | $18,413,000 | -39.2% | 781,185 | -21.2% | 2.35% | -23.0% |
| Q3 2018 | $30,297,000 | +2.2% | 991,711 | 0.0% | 3.05% | -20.1% |
| Q2 2018 | $29,652,000 | – | 991,711 | – | 3.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |